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1. Abstract
Colorectal cancer is one of the top leading causes of cancer deaths affecting people of
different ages, sex and races disproportionately. The American Cancer society researchers
have studied that lack of physical activities, smoking, consumption of red meat, and heavy
alcohol use to be high risk factors for developing colorectal cancer in addition to genetic
inheritances. Previous research studies have shown that disparities in cancer screening,
socioeconomic status and others impacts on colorectal cancer prevalence and death. The
objective of this project is to review the existing literature to better understand the disparities
in colorectal cancer prevalence and deaths in relation to patients’ demographic characteristics
mainly age, sex and race.
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2. Introduction
2.1 Colorectal Cancer
Cancer is one of the top four causes of death in the US and the rest of the world [1]. According to
the 2018 National Cancer Institute report, colorectal cancer was fourth most common cancer type
after breast, lung, and prostate cancers. In 2019 alone, 9.6 million people died from cancer
globally [1]. Six hundred thousand eight hundred eighty of those deaths took place in the US.
Additionally, in 2020 the US anticipated 1.8 million new cancer patients, as well as an estimated
606,520 deaths [2].
The term "colorectal cancer" (CRC) refers to the occurrence of uncontrolled cell growth in the
colon or rectum and its invasion of the normal cells [2]. Any cancer that affects the colon and the
rectum area is called colorectal cancer and it’s also known by other names such as bowel cancer,
colon cancer and rectal cancer. About 1 in 21 men and 1 in 23 women in the United States will
develop colorectal cancer throughout their lifespan according to the study conducted by The
American Cancer Society [3]. Staging is the process used to determine if cancer has advanced
with the colon, rectum, or to other parts of the body. To dictate the best treatment plan for
colorectal cancer, staging is particularly important. The process used to find out if cancer has
spread within the colon/rectum or to other part of the body is called staging. Staging is important
because it helps determine the best treatment plan. A commonly used system gives the stages a
number from 0 to 4. The stages of colon cancer are:
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Figure 1. Stages of colorectal cancer. NCI, NIH

Stage 0, is the earliest stage, when the cancer is still within the mucosa, or inner layer, of the
colon or rectum. It is also called carcinoma in situ. At stage 1, the cancer has grown through the
inner layer of the colon or rectum but has not yet spread beyond the wall of the rectum or colon.
Stage 2, the cancer has grown through or into the wall of the colon or rectum, but it has not yet
reached the nearby lymph nodes. At stage 3, The cancer has invaded the nearby lymph nodes,
but it has not yet affected other parts of the body. Stage 4 is the last stage and , the cancer has
spread to other parts of the body, including other organs, such as the liver, the membrane lining
the abdominal cavity, the lung, or the ovaries. Recurrent is the possibility of the cancer returning
after a patient has been treated. It may come back and affect the rectum, colon, same place the
first time you had it or another part of the body.

In 2020, the number of new cases of CRC is estimated to be around 147,950. The incidence of
colorectal cancer broadly waned around 1980s due to modifications in the vulnerability to some
risk factors and an increase in the early screening procedures [2]. The CRC rate has decreased
3

The prevalence of CRC is not uniform across the US population. Even though there is a small
percentage of colorectal cancer widespread that can be tied to heredity, most of it is caused due
the risk factors mentioned above and others [5, 6]. The objective of this study is to review the
association between the demographic factors race, sex, and age in conjunction with the
prevalence and death of CRC among the US population.
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3. Association Between Race and Colorectal Cancer Prevalence
Colorectal Cancer affects the African American community with higher rate of disease and
mortality compared to the rest of American communities. While the African American
colorectal cancer fatality rate has decreased since the 1980s, when compared to white
Americans, the incidence rate has increased by 11% [7]. Disparities in tumor diagnosis , patient
treatments, socioeconomic status, health care access and other criteria’s are identified as factors
that affect the outcome of colorectal cancer [7]. Despite adjustments for these factors in many
studies, disparities in CRC survival have persisted, worsened, and are not fully understood [7].
The National Cancer Institute studied differences in health care facilities of CRC and the race
disparities which have huge impact with follow-up colonoscopy after abnormal flexible
sigmoidoscopy [8].
Some of the variations of colorectal cancer found within the black community can be
linked to the population's low socioeconomic status. Education plays a critical role in influencing
the high number of cases in the community. A study carried out in Tennessee illustrated that
people who have attained higher education are 2.47 times likely to get screened for cancer than
those who do not [9]. Education also plays a critical role in influencing an individual's
socioeconomic status, which is directly linked to healthcare quality. Low education levels result
in most blacks working groups with low-paying jobs, which hinders them from accessing quality
care services and balanced diets, critical in an individual’s health [10]. Unfortunately, due to the
low economic status and the high inequalities in the US, the black community and other minority
groups have limited access to quality education and often do not attain a college degree.
Therefore, they are more likely not to get screened for cancer. The lack of screening during the
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early stages of cancer results in high mortality rates among the black communities compared to
their white counterparts.
Insurance coverage plays a critical role in ensuring that all citizens have access to quality
healthcare services. Despite affordable healthcare coverage such as Medicaid, Medicare, and
ACA, most minority communities remain uninsured. A 2020 report illustrates that 13.6% of
black Americans lack any form of insurance coverage [11]. This percentage illustrates a much
bigger minority population that lacks access to quality services due to lack of healthcare
coverage. The implication of no insurance coverage is the lack of access to services such as
screening or cancer treatment, which attributes to the region's high mortality rate.
Additionally, the African American population reported lower quality of health compared
to the white population; this is often associated with racial discrimination and inequality
regarding health care services. Acculturation also plays a critical role in the survival difference
observed between the different racial groups [12]. Compared to the white population, blacks,
Asians, and Hispanics have a lower mortality risk. However, their chronic disease morbidity
increases the more years they reside in their new country.
Different scholars have explored race and cancer-related death rates amid patients
diagnosed with colorectal cancer. For instance, a retrospective study by Fedewa et al. (2017)
examined the association between race and cancer mortalities. According to the study, colorectal
cancer is considered the third most public health concern that accounts for the highest mortality
and morbidity rates. The research indicates that the variance in colorectal cancer mortality
associated with race has been explored in-depth. Research showed that the African-American
population experience the highest percentage (32%) of death rates associated with colorectal
cancer [13]. The identified African American race risk was higher compared to the white
6

majority race. The study concluded a significantly heightened risk of death rates among the
Black Americans, Indians, and Native American patients compared to the white race. The study
incorporated 2,735 cases who were followed to evaluate the ethnic and racial disparities in the
incidence of colorectal cancer. The identified issues were assessed through a colonoscopy, an
intervention associated with a heightened risk for colorectal cancer[13]. Notably, the high
interval risk among the Black American groups appeared more profound in the rectal cancer.
Overall, among the participants enrolled for interventions, the Black populations exhibited
increased risk for incidence than the whites. The discrepancy was more evident for cancer of the
rectum and the distal colon.

Figure 2. Incidence and Mortality trends of Colorectal Cancer from 1970 to 2017.
Trends in Colorectal Cancer Incidence (1975 to 2016) and Mortality Rates and Rate Ratios (1970
to 2017) by Race, United States. Incidence rates exclude the appendix and are age adjusted to the 2000
US standard population and adjusted for reporting delays. White and black races are not mutually
exclusive from Hispanic ethnicity. Error bars indicate 95% confidence limits. The reference group for
7

mortality rate ratios is whites. Source: Incidence: SEER Program, 2019; Mortality: NCHS, 2019. Figure
2
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4. Association Between Age and Colorectal Cancer Prevalence
New research has shown that CRC is a significant concern among people aged 50 years and
below as newly diagnosed cases increase compared to those who are above 50 years old. This is
attributed to regular colonoscopies in recent years. Due to lack of regular screenings at an early
stage, most young patients tend to be exposed to CRC earlier than the accepted age for the
average risk person [16]. Research conducted in New Jersey has shown that, of all the yearly
diagnosed CRC cases, about 10% are young adults. [17].
Age and colorectal cancer are associated in significant ways. Approximately 90% of
patients diagnosed with colorectal cancer are aged 50 and above. Notably, smalls cancers are
difficult and challenging to recognize. Therefore, most of the cancers are identified at an advanced
age. The later diagnosis of the condition contributes to a poor prognosis [18]. This is because late
diagnosis implies delayed evaluation of the most appropriate intervention, increasing the
likelihood of complications. The American College of Gastroenterology recommends that African
Americans be screened for colon cancer at the age of 45 rather than 50, which is the approved age
for ordinary risky person of the general population[19]. Different studies have evaluated the
relationship between age and colorectal cancer. People growing older are highly likely to be
diagnosed with this type of cancer [20]. Essentially, non-concourses polyps are likely to divide to
form cancer cells. Therefore, older adults should remain vigilant and cautious to recognize early
signs for cancer development to minimize further complications.
Study reveal that approximately 50,000 adults are diagnosed with colorectal cancer [20].
Over the decades, the rates of colorectal cancer have dropped. The drop is associated with
increased testing and diagnosis, including screening. Multiple treatment modalities for the

9

condition also exist and contribute to better outcomes that have led to a decline in the incidences
of colorectal cancer among the groups [21].
Overall, advancement in age is linked to increased predisposition to diverse conditions—
notably, the prevalence of cancer and non-cancer. Some researchers have found that as individuals
grow older, they are at higher risk of suffering from colorectal cancer while other researchers have
found the opposite. The current diagnostic strategies have been beneficial towards ensuring the
rates of deaths associated with colorectal cancer become minimal. The plans remain effective in
ensuring individuals' lifespan are enhanced and that individuals typically live without their
comfortability and dignity of life interfered.

Figure 3. Trends in Adolescent and Young Adult Cancer Incidence and Mortality Rates for All Cancers
Combined by Age and Sex, 1975 to 2017. Rates are age adjusted to the 2000 US standard population, and
incidence rates are adjusted for reporting delays. Rates for those aged 15 to 19 years are 2‐year moving
averages.
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4.1 Relation effect of age on CRC with Obesity

Growing epidemiological data indicated a strong positive correlation between obesity and
colorectal carcinogenesis [23]. There is undeniable relationship between obesity and CRC, but
the seriousness of it has different outcome on different genders. obesity causes a higher risk of
colon cancer in males compared to females, and it has a stronger connection with colon cancer
than it does to rectal cancer in both females and males. Obesity is also believed to impose a
greater risk of colon cancer for premenopausal women than it does for postmenopausal
women[24]. Answers to why obesity increase the risk of colon cancer and why does it impose
greater risk of colon cancer for premenopausal women than it does for postmenopausal
women are not definitive , but obesity and menopausal status are strong determinants of
concentrations for various that may be critical for colon carcinogenesis. Some hormonal axes
such as estrogen, insulin, and Insulin-like growth factors (IGFs) may be linked to the issue[25].
Obesity is one of the risk factors that increase colorectal cancer among adults aged less than 45.
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Dose-response meta-analysis reported that body weight gain of 10 kg was accompanied by
approximately 8% increased risk of CRC [23]. Individuals who suffer early life obesity are at
greater risk of developing CRC in their adulthood. Obesity and overweight was found to be
responsible for around 11% of colorectal cancer (CRC) cases in Europe alone [26]. According to
epidemiological data, obese men have 30-70% increased risk of colon cancer compared to
women whose relation is less consistent.

Age

Obesity

CRC

Fig. 4 relation of age with CRC
As expected, body weight loss by bariatric surgery reduces about 27% risk of CRC [23].
Regular exercise plays a massive role in reducing the risk of developing colon cancer and the
risk of death from colon cancer should it develop. When it comes to assessing obesity risk of
developing colon cancer, wait circumference (WC) and body mass index (BMI) measurements
are recommended. Visceral abdominal fat radiographic assessment is believed to be the best
technique to evaluate if the patients colon cancer development is related to the persons obesity
[24].
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Table 1. Obesity and risk of developing colon cancer
Study

Study type

Population

N

CRC risk obese

conclusion

versus nonobese
Dai et al.

Meta-

2007

analysis

International

6,458

RR 1.37 for males

Obese men have
increased risk of
CRC

Polednak

Meta-

2008

analysis

American

153,760

RR 1.4 for males RR

Obese men have

1.1 for females

greater risk of
CRC

Harriss et al.

Meta-

2009

analysis

International

67,361

RR 1.24 for males

Higher BMI

RR 1.09 for females

increases risk of
colon cancer. Men
have greater risk
than women.

Pischon et

Prospective

al. 2006

cohort

European

368,272

RR 1.55 for males

Obese men have

RR 1.06 for females

greater risk of
CRC

Rapp et al.

Prospective

2005

cohort

Austrian

145,000

HR 1.56 for males

Obese men have

and colon cancer HR

greater risk of

1.11 for females and

CRC. Obese

colon cancer HR

women’s have

1.66 for cancer.

greater risk of

males and rectal

colon cancer

cancer HR 0.66 for

relative to rectal

females and rectal
cancer

A meta-analysis of 153,760 Americans conducted by Polednak revealed that the relative
risk for developing CRC was 1.4 for obese men and 1.1 for obese women. Another metaanalysis performed by Harris et al. that included 28 studies and international population of
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67,361 in search of relationship to determine the association between obesity and CRC, obese
men had a relative risk of 1.24 for developing colon cancer compared to obese women with a
relative risk of 1.09. [27]

5. Association Between Sex and Colorectal Cancer Prevalence
The prevalence and morbidity associated with colorectal cancer are not uniform across all
genders. Females have a lower rate of death than males statistically [28]. Hormone replacement
therapy is one factor that affects the regulation of hormones, especially at the menopausal stage.
This decreases development and differentiation of colorectal cancer in women[28]. The outcome
of external and internal pre-diagnosis factors lead to an increase in the number of cases, and
screening uptake reduces the risk in men compared to women [29].
Age and sex are regarded as predictive aspects among patients diagnosed with colorectal
cancer for receiving immune checkpoint inhibitors. Sex impacts diverse elements among patients
diagnosed with colorectal cancer. Researchers sought to evaluate the influence of sex on
chemotherapy intervention toxicity and its efficacy. They pooled distinct data sets that emanated
from selected clinical trials, evaluates the prevalence of CRC by sex [30] . From the research, the
participants (both male and female) were identified and distinguished into two groups when they
were compared. The study found that from the identified subjects, the chemotherapy regimen
gave higher incidences of side effects [31]. Despite this, it did not offer vital information
regarding the adverse effects observed among the female and the male categories of patients.
Given this, future studies should explore the concern to identify the impact of sex on colorectal
cancer. The study concluded that males and females possess divergent patterns through which
colorectal cancer can manifest. Notably, women have a higher risk of diabetes and other
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comorbid conditions, which increases their predisposition. Despite this, there is an increased
association of colorectal cancer in men when compared to women [32].
Cancers of any type are considered dangerous ailments given their rapid growth and
metastasis to other tissues, making them challenging to control. Notably, the development of
appropriate treatment strategies necessitates careful assessment. This involves evaluating the
myriad influences, including gender, on the desired patients' outcomes. Different type of studies
have been explored to gain a better understanding of the association between gender and
colorectal cancer [33]. A meta-analysis study by (Yang et al., 2017), examined the influence of
gender on different health outcomes, i.e., general and cancer-specific survival.

Figure 5. Flowchart of the literature search
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The information included in the study was gathered from diverse online databases, and
the documented clinical trials were compared, including the difference diagnosis obtained from
the male and the female forms of gender. The identified study enrolled a group of participants
diagnosed with colorectal cancer [34]. The males and females evaluated for the study were
obtained from varying listed traits that were documented. From the study, the results from the
overall survival and cancer-specific survival were established and compared. From the study, the
females exhibited better outcomes compared to males. It was concluded that the male population
has a higher risk for colorectal cancer compared to their female counterparts. Overall, the study
concludes the existence of gender influence on the survival rates of those diagnosed with
colorectal cancer.
Gender differences influence the quality of life among diverse patients under the medical
and other procedures in managing colorectal cancer [35]. Cross-sectional study was completed to
evaluate the distinct gender representations and their influence on the quality of life for patients
receiving treatment for colorectal cancer [36]. The study incorporated 144 patients from which
72 were males, and the other 72 made up the female gender set who were on treatment
interventions for colorectal cancer. The data included for the study entailed a combination of
clinical and sociodemographic factors, which provided information on the health-related life
quality with the treatment strategies for individuals diagnosed with colorectal cancer. The article
reveals that colorectal cancer is a significant public health concern across the region.
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Table 2. Comparison of men and women in relation to general quality of life (EORTC-QLQ-Q30)
EORTC QLQ-C30

Male (n=72)
Mean
Standard
deviation

Functional scale
Physical Function
82.78
Role Performance
83.80
Cognitive Function
88.89
Emotional Function
78.01
Social Function
81.94
Scale of symptoms
Fatigue
21.60
Pain
9.95
Nausea/ Vomiting
12.04
Dyspnea
7.87
Insomnia
20.37
Lack of appetite
/Anorexia
14.35
Constipation
7.41
Diarrhea
18.52
Financial problems 22.54
General health
status
73.96

Female (n=72)
Mean
Standard
deviation

p Value

18.70
22.50
16.80
21.95
27.79

76.53
78.17
78.64
70.19
73.94

23.68
22.54
22.39
26.78
29.64

0.082
0.191
0.002
0.058
0.098

25.35
18.27
18.60
20.55
30.92

22.85
11.97
17.37
7.98
26.29

27.53
23.60
25.57
19.89
35.14

0.779
0.568
0.156
0.974
0.287

28.97
22.53
30.58
32.745

21.60
12.21
16.90
27.70

34.31
26.57
25.11
36.07

0.175
0.246
0.730
0.373

22.68

78.05

21.39

0.269

On the other hand, females depicted a higher incidence of colorectal cancer of 8.6% from
their male counterparts. Hereditary factors contribute to the rise in the predisposing factors to the
condition. Therefore, numerous studies directly examine the association between gender and the
adverse effects of the disease process on the victim's quality of life. According to Trinquinato et
al. (2017) ) gender differences are associated with colorectal cancer and they should be evaluated
to identify whether each gender can protect themselves from the colorectal cancer. The study
presents the gender difference among males and females to include social, individual, cognitive
and physical. The identified variables play a pivotal role in investigating gender differences since
they reflect unique coping strategies and the influence of the identified condition's treatment
process. Adverse impacts of colorectal cancer lower the overall quality of life. As indicated in
17

the study, males are at advanced level risk of getting colorectal cancer compared to their female
counterparts [36]. Therefore, among the patients diagnosed with colorectal cancer, males are
more likely to have their cognition significantly impacted by the condition. Given this, men
depict a more significant impact of cognitive impairment on the situation, reflecting on the lower
quality of life. Essentially, cognitive function among patients diagnosed with colorectal cancer
contributes to a drop in the quality of life among the male population cohorts compared to the
females. The male gender diagnosed with the condition have a reduced quality of life due to the
prevalence of the symptoms such as fecal incontinence, and other features.
A study that explores this topic presents influences of gender in an individuals' lifestyle
choices and contributes to the high mortality rates associated with the condition. Notably,
research patterns reveal the influence of western lifestyle practices and their association with
obesity, hypertension, and other diseases. Particularly, females are the victim of poor dietary
patterns and lack of physical activities compared to males, who are often involved in heavy tasks
[37]. These risk factors, i.e., sedentary lifestyles and other unhealthy behavioral patterns,
increase the likelihood of colorectal cancer among females. Despite females being highly
predisposed, males exhibiting sedentary lifestyles should also alter their ways and evaluate their
ability to prevent the development of neoplastic ailments and other complications. According to
Conti et al. (2020), gender disparities contribute to neglecting management issues and providing
the best treatment approaches for the condition. Therefore, the article aimed to reevaluate
lifestyle factors and the risks of colorectal cancer from a gender perspective. Overall, appropriate
dietary and lifestyle practices should be designed to limit the predisposition to neoplastic
conditions for both men and women [38]. Modification of the lifestyle practices will reduce the
adverse effects associated with the development of cancer. Adapting these strategies would help
18

generate a healthier community whereby one gender is never overburdened with the actual
neoplastic disease process and other adverse consequences of unique practices.

6. Limitations
The study's main limitation is the lack of individual indicators of hormonal status, including
detailed information on the menopause state. This resulted to getting different results compared to
those gotten by previous researchers. However, this limitation is common among registry-based
studies, and it may be impossible to include information if it is unavailable in population-based
registries. The identified sampling method does not facilitate the identification of subjects but aids
in evaluating variables that affect the quality of life in both genders diagnosed with colorectal
cancer. Some studies found men to have higher colorectal incidence over women and some studies
proved otherwise. The etiology of gender differences in CRC is complex, and many factors may
require further investigation. Moreover, the study does not warrant the combination of clinical
features and demographic factors that facilitate a reliable comparison of a patient’s quality of life.
Therefore, future studies should evaluate both randomized and empirical aspects to facilitate robust
comprehension of the association between gender and colorectal cancer.
The study about obesity having stronger connection to colon cancer compared to rectal
cancer and why it impose a greater risk of colon cancer for premenopausal women than it does
for postmenopausal women has a interest of conflict and more studies need to be conducted on
the subject for better findings.
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7. Conclusion
Colorectal cancer is a significant cause of death in both the United States and the world, and its
prevalence depends on different factors, including race, age, and sex. As much as colorectal
cancer incidence has reduced over the years, it still causes many deaths. With technology
changes, enhanced screening and treatments have led to the decrease in the prevalence and death
of CRC in people less than 55 years old. Males aged below 45 years are advised to exercise as
this reduces their chances of presenting with colorectal cancer, and more people are doing that
every day. Both men and women are also advised to avoid alcohol and smoking, reduce the
consumption of red meats, and more people are switching to vegetarian diets, contributing to the
decreasing numbers.
Males should adopt the aforementioned CRC risk reducing recommendations since they
are at higher risk of getting colorectal cancer compared to women. Studies about racial disparity
have shown that African Americans are more susceptible to colorectal cancer, and have higher
rate of mortality than other races. Fatalities have been simultaneously decreasing among whites
Americans while increasing among African-Americans. One contributing factor to this is that the
socioeconomic status in African-America is lower, though other factors also play a role in this
disparity. In terms of age, younger people are more frequently diagnosed with CRC compared to
older people (over 50 years) since they follow up with a colonoscopy. People are advised to take
up regular screening so that treatment can happen at an early stage to control CRC. Poor eating
habits among young people have caused obesity, which increases the risk of colorectal cancer.
All individuals are at risk of suffering from colorectal cancer. everyone needs to take care
of the of the illness and always seek medical care if they have signs and symptoms related to
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cancer. People should take all the necessary precautions to protect themselves from colorectal
cancer since it has become killer disease. Even though people of certain ages, races and sex are
at a higher risk than others, almost everyone is at a risk of getting CRC. Therefore, following the
risk mitigation recommendations like early screening and lifestyle changes are necessary reduce
the prevalence and death of CRC worldwide.
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